CYP2C19andPON1polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects Academic Article uri icon


  • AIM, MATERIALS & METHODS: We investigated the functional significance of CYP2C19*2, *3, *17 and PON1 Q192R SNPs in 89 consecutive Asian patients on clopidogrel treatment and the prevalence of functionally significant polymorphisms among 300 Chinese, Malays and Asian Indians.Both CYP2C19 loss-of-function alleles (*2 or *3) were associated with higher platelet reactivity while the CYP2C19 gain-of-function allele (*17) had lower platelet reactivity. For PON1, the median PRI was not significantly different between the QQ, QR and RR groups. The allele frequencies of CYP2C19*2, CYP2C19*3 and CYP2C19*17 were 0.280, 0.065 and 0.010 (rare) for Chinese, 0.310, 0.050 and 0.025 for Malays, and 0.375, 0.010 (rare) and 0.165 for Indians, respectively.Our data suggest that genotyping studies to investigate clopidogrel response should include CYP2C19*2 and *3 but not *17 polymorphisms in Chinese, and CYP2C19*2 and *17 polymorphisms but not *3 in Indians. All three polymorphisms should preferably be genotyped in Malays.


  • Chan, Mark Y
  • Tan, Karen
  • Tan, Huay-Cheem
  • Huan, Pei-Tee
  • Li, Bei
  • Phua, Qian-Hui
  • Lee, Hong-Kai
  • Lee, Chi-Hang
  • Low, Adrian
  • Becker, Richard C
  • Ong, Wen-Chong
  • Richards, Mark A
  • Salim, Agus
  • Tai, E-Shyong
  • Koay, Evelyn

publication date

  • April 2012

has subject area